|
Yale SPORE in Skin Cancer
|
5P50CA121974-03
|
$2,233,298
|
$245,663
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$151,177
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
7R37CA071692-12
|
$348,711
|
$87,178
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-02
|
$297,374
|
$297,374
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Wnt antagonist genes in kidney tumor progression and metastasis
|
1R01CA130860-01
|
$600,893
|
$600,893
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
Wine for Cancer-Associated Anorexia
|
5R01CA124614-02
|
$1,354
|
$1,354
|
JATOI, AMINAH
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Whole Body Hyperthermia and Anti-Tumor Immune Response
|
5R01CA071599-10
|
$283,824
|
$85,147
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$316,550
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
VPF/VEGF in normal and neoplastic skin angiogenesis
|
5R01CA069184-13
|
$145,925
|
$72,963
|
DETMAR, MICHAEL
|
SWISS FEDERAL INST OF TECH (ETH ZURICH)
|
|
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
|
2R01CA095045-06
|
$270,000
|
$270,000
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-02
|
$1,035,536
|
$517,768
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
VHL and FGFR signaling in angiogenesis
|
5R01CA109860-05
|
$283,792
|
$283,792
|
HSU, TIEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VEGF-based Targeted Imaging of Tumor Vasculature
|
5R44CA113080-03
|
$564,762
|
$564,762
|
Backer, Joseph
|
SIBTECH, INC.
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
5R01CA064436-12
|
$271,728
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
VEGF Induced Signal Transduction
|
5R01CA086289-09
|
$301,024
|
$75,256
|
SIBINGA, NICHOLAS
|
YESHIVA UNIVERSITY
|
|
Vav3 Oncogene in Prostate Cancer
|
5R01CA119935-02
|
$266,760
|
$266,760
|
LU, SHAN
|
UNIVERSITY OF CINCINNATI
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
2R01CA103986-04A1
|
$254,023
|
$254,023
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
1P50CA128323-01A1
|
$1,500,000
|
$150,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of genomic targets in melanoma
|
5R01CA114337-04
|
$288,354
|
$288,354
|
KASHANI-SABET, MOHAMMED
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$7,195
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$575,458
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-04
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-05
|
$2,158,606
|
$431,721
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$158,289
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using NMD to identify Mutated genes in colon cancer
|
5R01CA109256-05
|
$328,360
|
$328,360
|
IONOV, YURIJ
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Using New Optical Techniques to Study Cell Signaling in 3D Matrices
|
1R21CA126635-01A1
|
$147,000
|
$147,000
|
KEELY, PATRICIA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence
|
5R03CA128110-02
|
$77,000
|
$77,000
|
STURGIS, ERICH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-08
|
$263,273
|
$263,273
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
Z01 BC 010871
|
$383,517
|
$191,759
|
Merlino, Glenn
|
CCR (NCI)
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
5R01CA114039-04
|
$255,871
|
$255,871
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER
|
|
Use of Adjuvants to Improve Skin Genetic Immunizations
|
5R01CA100893-05
|
$256,287
|
$128,144
|
LARREGINA, ADRIANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of aAPC for melanoma adoptive immunotherapy
|
5R01CA108835-05
|
$317,808
|
$317,808
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-33S1
|
$74,165
|
$8,900
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-33
|
$6,658,653
|
$799,038
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urokinase Receptor-initiated Cell-signaling
|
5R01CA094900-08
|
$268,414
|
$268,414
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Urokinase Receptor Integrin Interactions in Lung Cancer
|
5R01CA125564-02
|
$293,471
|
$293,471
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
2U54CA096297-06A1
|
$1,584,860
|
$126,789
|
FRONTERA-ROURA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$14,578
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-24
|
$1,553,887
|
$279,700
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-04S1
|
$60,563
|
$6,662
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-04
|
$1,332,378
|
$146,562
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$7,327
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$719,362
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$278,086
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S4
|
$2,630,152
|
$157,809
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S5
|
$61,584
|
$3,695
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Unexpected Roles for the alpha2beta1 Integrin
|
5R01CA115984-04
|
$287,453
|
$71,863
|
ZUTTER, MARY
|
VANDERBILT UNIVERSITY
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
1K07CA130983-01A1
|
$126,591
|
$126,591
|
RIALL, TAYLOR
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Understanding the Role of Autophagy in Cancer
|
5F32CA123777-03
|
$51,278
|
$51,278
|
DORSEY, FRANK
|
SCRIPPS RESEARCH INSTITUTE
|
|
Ultrastaging of Early Colon Cancer
|
2R01CA090848-05A2
|
$269,999
|
$269,999
|
BILCHIK, ANTON
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Metastasis for this search: $366,310,151
|